APO RESEARCH · REPORT
Glucagon
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Product & engineering
Understand the product.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Selected research
Industry Research
Glucagon Industry Research Report 2026
Market perspective
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
Report Scope
Read the full market overview
This report quantifies the global Glucagon market in terms of revenue (US$ million) and, where applicable, sales volume (K MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glucagon Market by Company
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Glucagon Segment by Type
Inject Glucagon
Nasal Glucagon
Glucagon Segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Glucagon Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glucagon manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glucagon by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glucagon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Inject Glucagon
- Nasal Glucagon
Applications
- Emergency Kits
- General Use
- Diagnostic & Motility
- Cardiogenic Shock
- Others
Companies covered
- Novo Nordisk
- Eli Lilly
- Fresenius Kabi
- Torrent Labs
- Taj Pharmaceuticals
- Xeris Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glucagon Market Size (2021-2032)
- 2.2.2 Global Glucagon Sales (2021-2032)
- 2.2.3 Global Glucagon Market Average Price (2021-2032)
- 2.3 Glucagon by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Inject Glucagon
- 2.3.3 Nasal Glucagon
- 2.4 Glucagon by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Emergency Kits
- 2.4.3 General Use
- 2.4.4 Diagnostic & Motility
- 2.4.5 Cardiogenic Shock
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glucagon Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glucagon Sales (K MT) of Manufacturers (2021-2026)
- 3.3 Global Glucagon Revenue of Manufacturers (2021-2026)
- 3.4 Global Glucagon Average Price by Manufacturers (2021-2026)
- 3.5 Global Glucagon Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glucagon, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glucagon, Product Type & Application
- 3.8 Global Manufacturers of Glucagon, Established Date
- 3.9 Global Glucagon Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novo Nordisk
- 4.1.1 Novo Nordisk Company Information
- 4.1.2 Novo Nordisk Business Overview
- 4.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novo Nordisk Glucagon Product Portfolio
- 4.1.5 Novo Nordisk Recent Developments
- 4.2 Eli Lilly
- 4.2.1 Eli Lilly Company Information
- 4.2.2 Eli Lilly Business Overview
- 4.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly Glucagon Product Portfolio
- 4.2.5 Eli Lilly Recent Developments
- 4.3 Fresenius Kabi
- 4.3.1 Fresenius Kabi Company Information
- 4.3.2 Fresenius Kabi Business Overview
- 4.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fresenius Kabi Glucagon Product Portfolio
- 4.3.5 Fresenius Kabi Recent Developments
- 4.4 Torrent Labs
- 4.4.1 Torrent Labs Company Information
- 4.4.2 Torrent Labs Business Overview
- 4.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Torrent Labs Glucagon Product Portfolio
- 4.4.5 Torrent Labs Recent Developments
- 4.5 Taj Pharmaceuticals
- 4.5.1 Taj Pharmaceuticals Company Information
- 4.5.2 Taj Pharmaceuticals Business Overview
- 4.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
- 4.5.5 Taj Pharmaceuticals Recent Developments
- 4.6 Xeris Pharmaceuticals
- 4.6.1 Xeris Pharmaceuticals Company Information
- 4.6.2 Xeris Pharmaceuticals Business Overview
- 4.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
- 4.6.5 Xeris Pharmaceuticals Recent Developments
5 Global Glucagon Market Scenario by Region
- 5.1 Global Glucagon Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glucagon Sales by Region: 2021-2032
- 5.2.1 Global Glucagon Sales by Region: 2021-2026
- 5.2.2 Global Glucagon Sales by Region: 2027-2032
- 5.3 Global Glucagon Revenue by Region: 2021-2032
- 5.3.1 Global Glucagon Revenue by Region: 2021-2026
- 5.3.2 Global Glucagon Revenue by Region: 2027-2032
- 5.4 North America Glucagon Market Facts & Figures by Country
- 5.4.1 North America Glucagon Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glucagon Sales by Country (2021-2032)
- 5.4.3 North America Glucagon Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glucagon Market Facts & Figures by Country
- 5.5.1 Europe Glucagon Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glucagon Sales by Country (2021-2032)
- 5.5.3 Europe Glucagon Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glucagon Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glucagon Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glucagon Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glucagon Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glucagon Market Facts & Figures by Country
- 5.7.1 South America Glucagon Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glucagon Sales by Country (2021-2032)
- 5.7.3 South America Glucagon Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Glucagon Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glucagon Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glucagon Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glucagon Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glucagon Sales by Type (2021-2032)
- 6.1.1 Global Glucagon Sales by Type (2021-2032) & (K MT)
- 6.1.2 Global Glucagon Sales Market Share by Type (2021-2032)
- 6.2 Global Glucagon Revenue by Type (2021-2032)
- 6.2.1 Global Glucagon Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glucagon Revenue Market Share by Type (2021-2032)
- 6.3 Global Glucagon Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glucagon Sales by Application (2021-2032)
- 7.1.1 Global Glucagon Sales by Application (2021-2032) & (K MT)
- 7.1.2 Global Glucagon Sales Market Share by Application (2021-2032)
- 7.2 Global Glucagon Revenue by Application (2021-2032)
- 7.2.1 Global Glucagon Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glucagon Revenue Market Share by Application (2021-2032)
- 7.3 Global Glucagon Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glucagon Value Chain Analysis
- 8.1.1 Glucagon Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glucagon Production Mode & Process
- 8.2 Glucagon Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glucagon Distributors
- 8.2.3 Glucagon Customers
9 Global Glucagon Analyzing Market Dynamics
- 9.1 Glucagon Industry Trends
- 9.2 Glucagon Industry Drivers
- 9.3 Glucagon Industry Opportunities and Challenges
- 9.4 Glucagon Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst